首页 › 基金 › BML Capital Management, LLC › KPTI

BML Capital Management, LLC 对 KPTI 的持仓历史

KARYOPHARM THERAPEUTICS INC · 医疗保健

BML Capital Management, LLC 在 Q3 2026 的 13F 申报中披露持有 KPTI(KARYOPHARM THERAPEUTICS INC)71,839 股,市值约 US$88K,约占其申报组合的 0.05%,在其申报持仓中市值排名第 20 位。 BML Capital Management, LLC 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)71.84K 股
申报持仓市值$87.64K
组合权重0.05%
首次申报Q3 2026
最近变动新进
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

BML Capital Management, LLC 对 KPTI 的持仓演变

BML Capital Management, LLC 于 Q3 2026 首次披露 KPTI 持仓:71,839 股(约 US$88K)。

逐季持仓明细

季度股数金额变化
Q3 2026 71.84K $87.64K 新进

关于 KPTI 与 13F 数据

KPTI(KARYOPHARM THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 27 只申报持有 KPTI,申报仓位最大的包括:ACORN CAPITAL ADVISORS, LLC (US$14.8M), Catalio Capital Management, LP (US$9.2M), Avidity Partners Management LP (US$9.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 KPTI 的基金

查看 KPTI 的全部基金持有人 →

常见问题

How long has BML Capital Management, LLC held KPTI?

BML Capital Management, LLC has disclosed KPTI holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is BML Capital Management, LLC's current position in KPTI?

As of Q3 2026, BML Capital Management, LLC holds 71.84K shares of KPTI (KARYOPHARM THERAPEUTICS INC), valued at $87.64K, representing 0.05% of its reported portfolio and ranking #20.

Has BML Capital Management, LLC been buying or selling KPTI?

In the latest 13F filing (Q3 2026), BML Capital Management, LLC newly opened its position in KPTI.

Which other funds hold KPTI?

Other major institutional holders of KPTI include ACORN CAPITAL ADVISORS, LLC, Catalio Capital Management, LP, Avidity Partners Management LP, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.